Richard S. Hann

Thomas Jefferson University Hospital — United States

Medicine · Health Sciences

11h-index460citations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(8), Liver Disease Diagnosis and Treatment(7), Hepatitis C virus research(5), Telomeres, Telomerase, and Senescence(5), Hepatocellular Carcinoma Treatment and Prognosis(3)

Publications17 total

Persistent Risk for Hepatocellular carcinoma in patients on antiviral treatment: A Need for HBV cure
Integrative Cancer Science and Therapeutics·2018· 1 citedOpen Access
Persistent Risk for HBV Associated Hepatocellular Carcinoma in spite of Sustained and Successful Viral Suppression: The Need for Drugs for HBV Cure
Cancer Studies·2017Open Access
Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients
Carcinogenesis·2017· 11 citedOpen Access
Prospective evidence of a circulating microRNA signature as a non-invasive marker of hepatocellular carcinoma in HBV patients
Oncotarget·2016· 15 citedOpen Access
Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
Scientific Reports·2016· 92 citedOpen Access
Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study
Digestive Diseases and Sciences·2015· 15 cited
Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis <scp>B</scp> virus infection
Journal of Gastroenterology and Hepatology·2014· 31 citedOpen Access
A long‐term study of the effects of antiviral therapy on survival of patients with <scp>HBV</scp>‐associated hepatocellular carcinoma (<scp>HCC</scp>) following local tumor ablation
Cancer Medicine·2014· 34 citedOpen Access
Abstract 110: Prospective and longitudinal evaluations of telomere length in circulating serum DNA as a noninvasive risk factor of hepatocellular carcinoma in HBV patients.
Cancer Research·2013
Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients
PLoS ONE·2012· 86 citedOpen Access
Telomere length in circulating serum <scp>DNA</scp> as a novel non‐invasive biomarker for cirrhosis: a nested case–control analysis
Liver International·2012· 20 citedOpen Access
Abstract 4462: Relative telomere length in circulating serum DNA as a novel non-invasive biomarker in hepatocarcinogenesis
Cancer Research·2012
Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection
European Journal of Cancer·2012· 55 citedOpen Access
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection – Results from a clinic-based longitudinal cohort
European Journal of Cancer·2012· 26 citedOpen Access
Hepatitis B Virus Infection in 6,130 Unvaccinated Korean-Americans Surveyed Between 1988 and 1990
The American Journal of Gastroenterology·2007· 48 cited
Effects of isoferritins on human granulocytes
Cancer·1989· 26 citedOpen Access
Leukocyte migration inhibition of leukemia-associated antigen in children with acute leukemia and their family members
Cancer·1980

Frequent Co-authors

Shaogui Wan(11), Ronald E. Myers(11), Hushan Yang(11), Hie‐Won Hann(10), Jinliang Xing(9), Hie‐Won Hann(6), Yinzhi Lai(4), Xiaoying Fu(4), Zhong Ye(3), Bicui Chen(3), Chun Wang(2), Xishan Ye(2), Bingshan Li(2), Kejin Zhang(2), W. Thomas London(2), Heng Tang(2), Chun Wang(2), Ling Li(1), Alison A. Evans(1), Jennifer Au(1)